Associate Director - Biomarker Project Lead
Novartis
- Bâle
- CDI
- Temps-plein
As the BML (BioMarker Development project Lead) in Biomedical Research/Translational Medicine/Biomarker Development (BMD) you will be responsible for:Major Accountabilities (Core Responsibilities)
- BMD strategic leader at project level and supports biomarker plan excellence with concise communication of the biomarkers in relation to compound/disease biology and impact.
- The Biomarker Development project lead Lead (BML) will be the BMD representative at DTB/DADB for the project/ portfolio.
- Accountable for the biomarker strategy at a study level in coordination with the respective study lead, ensures alignment for projects within the disease area or across assets.
- Representing BMD line functions in Therapeutic Area Line Function committees for clinical protocol development and operational milestone reviews.
- Is responsible for the concept, endorsement, implementation, delivery and contextualization of the biomarker strategy and plan.
- Reports to Therapeutic Area Biomarker Head (TABH) or Therapeutic Area Biomarker Lead (TABL) and cooperates closely to enable the project/study level biomarker strategy at concept and contextualizing stages.
- Leads the biomarker subteam and the Development biomarker clinical subteam to align all key stakeholders on the biomarker strategy and plan at the project/study level and across their portfolio.
- Aligns with the TABL/TABH to deliver on BMD TA strategy and initiatives.
- Aligns with TABL for the attendance and representation for project teams at ePTs and GPTs.
- Is an enterprise partner and strategic leader in the matrix environment, able to integrate and represent projects in the internal/external scientific discussions and initiatives.
- Representative at key meetings including DADB and DTB for study level reviews and milestones.
- Accountable for the biomarker strategy for their respective disease area or project
- May act as a Biomarker Lead at the study level.
- MD, MD/PhD, or PhD degree required, plus additional PhD/postdoc or equivalent level research
- Scientific excellence, or clinical expertise in neuroscience diseases/biology, or BM expertise evidenced by previous role or contributions in Neuroscience
- Experience in industry (Pharma or Biotech) for at least 3-5 years.
- Understanding of integrating a variety of biomarker modalities, and experience interacting with the various stakeholders within the organisation to ensure timely execution of plans and feasibility of implementing the proposed strategies in the clinical studies.
- Proven success in leading matrix (global, cross functional) teams including well developed interpersonal, communication (oral and written) and influencing skills
- Creative and innovative leadership with a sharp and objective intellect, and experience in balancing big picture thinking with detailed analysis
- Demonstrated passion for science, seeking out new clinical discovery opportunities and early clinical study approaches and ability to leverage KOL's in the field.